XORTX Therapeutics (XRTX) Intangibles (2020 - 2026)
XORTX Therapeutics (XRTX) posted Intangibles of $185695.0 for Q1 2026, little changed on a QoQ basis from $185367.0 in Q4 2025, and up 3.18% year-over-year from $179972.0 in Q1 2025.
XORTX Therapeutics (XRTX) Intangibles (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Intangibles history runs 7 years deep, the most recent figure standing at $185695.0 for Q1 2026.
- Quarterly Intangibles rose 3.18% year-over-year to $185695.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $185695.0 (up 3.18% YoY) and the FY2025 annual result came in at $185367.0, up 1.23% from the prior year.
- Intangibles was $185695.0 for Q1 2026 at XORTX Therapeutics, roughly flat from $185367.0 in the prior quarter.
- Across five years, Intangibles topped out at $336803.0 in Q4 2023 and bottomed at $162360.0 in Q2 2023.
- A 5-year average of $193274.6 and a median of $185695.0 in 2026 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2023 — Intangibles jumped 68.91% — and 2024, when it plunged 45.63%.
- XORTX Therapeutics' Intangibles stood at $199401.9 in 2022, then jumped by 68.91% to $336803.0 in 2023, then plunged by 45.63% to $183108.0 in 2024, then rose by 1.23% to $185367.0 in 2025, then advanced by 0.18% to $185695.0 in 2026.
- Business Quant data shows XRTX's Intangibles at $185695.0 in Q1 2026, $185367.0 in Q4 2025, and $193997.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - | 185,695.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 185,695.00 |
| Dec 31, 2025 | 185,367.00 |
| Sep 30, 2025 | 193,997.00 |
| Jun 30, 2025 | 195,008.00 |
| Mar 31, 2025 | 179,972.00 |
| Dec 31, 2024 | 183,108.00 |
| Sep 30, 2024 | 185,703.00 |
| Jun 30, 2024 | 168,911.00 |
| Mar 31, 2024 | 165,991.00 |
| Dec 31, 2023 | 336,803.00 |
| Sep 30, 2023 | 171,521.00 |
| Jun 30, 2023 | 162,360.00 |
| Mar 31, 2023 | 168,151.00 |
| Dec 31, 2022 | 199,401.91 |
| Sep 30, 2022 | 199,639.25 |
| Jun 30, 2022 | 202,878.34 |
| Mar 31, 2022 | 201,161.49 |
| Dec 31, 2021 | 203,286.82 |
| Sep 30, 2021 | 193,800.92 |
| Dec 31, 2020 | 249,432.37 |